Viktoria Laszlo, Ph.D.

2009 Semmelweis Egyetem, Hungary 
Pathology, Cell Biology
"Viktoria Laszlo"


Sign in to add mentor
Sandor Paku grad student 2009 Semmelweis Egyetem
 (Primer mitogenek hatasa patkanyban az ossejtek reszvetelevel zajlo majregeneraciora.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ghimessy AK, Gellert A, Schlegl E, et al. (2019) KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy. Cancers. 11
Vlacic G, Hoda MA, Klikovits T, et al. (2019) Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity. Cells. 8
Laszlo V, Valko Z, Ozsvar J, et al. (2018) The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma. Journal of Molecular Medicine (Berlin, Germany)
Klikovits T, Lohinai Z, Fábián K, et al. (2018) New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study. Lung Cancer (Amsterdam, Netherlands). 126: 139-148
Moll HP, Pranz K, Musteanu M, et al. (2018) Afatinib restrains K-RAS-driven lung tumorigenesis. Science Translational Medicine. 10
Laszlo V, Valko Z, Kovacs I, et al. (2018) Nintedanib is active in malignant pleural mesothelioma cell models and inhibits angiogenesis and tumor growth in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Schelch K, Wagner C, Hager S, et al. (2018) FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal. Carcinogenesis. 39: 534-545
Klikovits T, Stockhammer P, Laszlo V, et al. (2017) Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma. Scientific Reports. 7: 16456
Torok S, Rezeli M, Kelemen O, et al. (2017) Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors. Theranostics. 7: 400-412
Paku S, Laszlo V, Dezso K, et al. (2016) The evidence for and against different modes of tumour cell extravasation in the lung: diapedesis, capillary destruction, necroptosis and endothelialisation. The Journal of Pathology
See more...